Analyst Ratings for Emergent BioSolutions (EBS) [Sells]
EBS Rating Summary
EBS Price Target Summary
- Highest: $15.00 (TD Cowen)
- Lowest: $5.00 (Benchmark)
- Average: $8.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$8.50 (+271.2%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 67%
Avg. $ Target:
$8.50 (+271.2%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 67%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/20/2023 | JPMorgan | Jessica Fye | New Coverage | Underweight (N/A) |
N/A (N/A) |
2.12 (2.29) |
8.02% | Details |
